ONTOLOGY REPORT - ANNOTATIONS
| Term: | Colonic Neoplasms |
|
| Accession: | RDO:0005238
|
browse the term
|
| Definition: | Tumors or cancer of the COLON. |
| Synonyms: | exact_synonym: | Cancer of Colon; Cancer of the Colon; Colon Cancer; Colon Cancers; Colon Neoplasm; Colon Neoplasms; Colonic Cancer; Colonic Cancers; Colonic Neoplasm |
| | primary_id: | MESH:D003110 |
|
|
Colonic Neoplasms
|
| G |
Acvr2a |
activin A receptor, type IIA |
|
|
ISS |
3 |
29,779,827 |
29,808,881 |
RGD:2301065 |
RGD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
Onset |
IEP |
1 |
82,686,233 |
82,726,544 |
RGD:2313394 |
RGD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
Onset |
ISS |
1 |
82,686,233 |
82,726,544 |
RGD:2313394 |
RGD |
| G |
Anxa7 |
annexin A7 |
|
|
ISS |
15 |
4,047,956 |
4,075,981 |
RGD:2292654 |
RGD |
| G |
Apc |
adenomatous polyposis coli |
|
|
IPM |
18 |
26,732,147 |
26,790,383 |
RGD:1601201 |
RGD |
| G |
Apobec1 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 |
|
|
IEP |
4 |
159,033,170 |
159,048,108 |
RGD:625559 |
RGD |
| G |
Bard1 |
BRCA1 associated RING domain 1 |
|
|
IED |
9 |
70,120,151 |
70,198,591 |
RGD:632230 |
RGD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
|
IEP |
13 |
12,730,736 |
12,905,108 |
RGD:2293078 |
RGD |
| G |
Brca1 |
breast cancer 1, early onset |
|
Susceptibility |
ISS |
10 |
90,513,630 |
90,572,676 |
RGD:1599497 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
IEP |
10 |
70,256,263 |
70,258,061 |
RGD:5135051 |
RGD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
|
IEP |
10 |
71,744,559 |
71,746,109 |
RGD:5135051 |
RGD |
| G |
Ccnd2 |
cyclin D2 |
|
|
IEP |
4 |
163,523,817 |
163,546,501 |
RGD:2289181 |
RGD |
| G |
Ccne1 |
cyclin E1 |
|
|
IEP |
1 |
90,568,189 |
90,577,426 |
RGD:2289293 |
RGD |
| G |
Cd40lg |
CD40 ligand |
|
|
ISS |
X |
141,925,019 |
141,937,183 |
RGD:5490978 |
RGD |
| G |
Cd59 |
CD59 molecule, complement regulatory protein |
|
|
IPM |
3 |
89,243,600 |
89,245,129 |
RGD:1600485 |
RGD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
|
IEP |
5 |
108,908,749 |
108,916,380 |
RGD:1600823 |
RGD |
| G |
Col18a1 |
collagen, type XVIII, alpha 1 |
|
Severity |
IED |
20 |
11,920,816 |
11,982,468 |
RGD:1600901 |
RGD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
|
IAGP |
8 |
125,978,161 |
125,987,670 |
RGD:1599637 |
RGD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
Resistance |
IEP |
1 |
238,259,443 |
238,274,745 |
RGD:1600355 |
RGD |
| G |
Hpgd |
hydroxyprostaglandin dehydrogenase 15 (NAD) |
|
|
ISS |
16 |
37,419,901 |
37,457,896 |
RGD:5688759 |
RGD |
| G |
Hs3st2 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
|
|
ISS |
1 |
180,202,791 |
180,324,718 |
RGD:2317633 |
RGD |
| G |
Kdr |
kinase insert domain receptor |
|
|
ISS |
|
|
|
RGD:5684533 |
RGD |
| G |
Klf5 |
Kruppel-like factor 5 |
|
Model |
ISS |
15 |
83,103,177 |
83,118,363 |
RGD:1304288 |
RGD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
|
IEP |
1 |
196,629,366 |
196,866,937 |
RGD:1599637 |
RGD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
|
ISS |
1 |
195,310,027 |
195,336,224 |
RGD:6483523 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
Disease_progression |
IEP |
3 |
155,985,473 |
155,993,433 |
RGD:2325778 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
IED |
3 |
155,985,473 |
155,993,433 |
RGD:5135051 |
RGD |
| G |
Mre11a |
MRE11 meiotic recombination 11 homolog A (S. cerevisiae) |
|
|
ISS |
8 |
11,588,409 |
11,632,483 |
RGD:2317740 |
RGD |
| G |
Mtus1 |
microtubule associated tumor suppressor 1 |
|
|
ISS |
16 |
54,611,502 |
54,664,075 |
RGD:2317016 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
Treatment |
IED |
7 |
98,953,142 |
98,958,060 |
RGD:7240527 |
RGD |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
|
ISS |
19 |
19,662,337 |
19,697,341 |
RGD:5131515 |
RGD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
|
IED |
19 |
37,251,147 |
37,266,040 |
RGD:5133247 |
RGD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
|
ISS |
18 |
57,014,475 |
57,053,581 |
RGD:2292176 |
RGD |
| G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
|
ISS |
10 |
96,056,220 |
96,057,232 |
RGD:6771355 |
RGD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
|
ISS |
2 |
118,640,277 |
118,672,440 |
RGD:5685670 |
RGD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
|
ISS |
2 |
32,602,673 |
32,675,350 |
RGD:2290476 |
RGD |
| G |
Plau |
plasminogen activator, urokinase |
|
Treatment |
ISS |
15 |
3,680,072 |
3,686,232 |
RGD:7241805 |
RGD |
| G |
Plau |
plasminogen activator, urokinase |
|
|
ISS |
15 |
3,680,072 |
3,686,232 |
RGD:7241262 |
RGD |
| G |
Pms2 |
postmeiotic segregation increased 2 (S. cerevisiae) |
|
|
ISS |
12 |
11,004,507 |
11,028,754 |
RGD:1599141 |
RGD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
|
ISS |
4 |
151,492,220 |
151,617,331 |
RGD:1601444 |
RGD |
| G |
Prf1 |
perforin 1 (pore forming protein) |
|
|
IED |
20 |
28,658,367 |
28,663,877 |
RGD:6482822 |
RGD |
| G |
Prf1 |
perforin 1 (pore forming protein) |
|
|
ISS |
20 |
28,658,367 |
28,663,877 |
RGD:6482812 |
RGD |
| G |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
|
ISS |
2 |
54,327,821 |
54,360,462 |
RGD:5685669 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
IPM |
13 |
64,427,288 |
64,432,978 |
RGD:5135051 |
RGD |
| G |
Runx3 |
runt-related transcription factor 3 |
|
|
ISS |
5 |
153,950,116 |
153,973,141 |
RGD:2302551 |
RGD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
Disease_progression |
ISS |
3 |
148,157,256 |
148,170,524 |
RGD:1601371 |
RGD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
|
ISS |
8 |
120,593,595 |
120,680,453 |
RGD:2301065 |
RGD |
| G |
Tnfrsf17 |
tumor necrosis factor receptor superfamily, member 17 |
|
|
ISS |
10 |
4,187,672 |
4,193,420 |
RGD:2317311 |
RGD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
|
IEP |
4 |
162,172,563 |
162,185,252 |
RGD:5131434 |
RGD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
|
ISS |
5 |
163,666,541 |
163,697,484 |
RGD:5131434 |
RGD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
|
ISS |
9 |
10,520,730 |
10,536,071 |
RGD:5684533 |
RGD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
|
IEP |
9 |
10,520,730 |
10,536,071 |
RGD:5135051 |
RGD |
| G |
Vegfc |
vascular endothelial growth factor C |
|
|
IEP |
16 |
40,624,435 |
40,739,692 |
RGD:2315488 |
RGD |
| S |
BDII |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
F344-ApcPircUwm |
|
|
|
IED |
|
|
|
RGD:1601201 |
RGD |
| S |
WF |
Wistar Furth |
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
Adenomatous Polyposis Coli
|
| G |
Apc |
adenomatous polyposis coli |
|
|
ISS |
18 |
26,732,147 |
26,790,383 |
RGD:2293188 |
RGD |
| G |
Apc |
adenomatous polyposis coli |
|
|
IEA |
18 |
26,732,147 |
26,790,383 |
RGD:1331525 |
RGD |
| G |
Apc |
adenomatous polyposis coli |
|
|
ISS |
18 |
26,732,147 |
26,790,383 |
RGD:7240710 |
OMIM |
| G |
ApcPirc |
adenomatous polyposis coli |
|
|
IED |
|
|
|
RGD:1601201 |
RGD |
| G |
Bmpr1a |
bone morphogenetic protein receptor, type IA |
|
|
ISS |
16 |
10,061,943 |
10,105,854 |
RGD:734650 |
RGD |
| G |
Mutyh |
mutY homolog (E. coli) |
|
|
ISS |
5 |
137,103,958 |
137,115,897 |
RGD:1600191 |
RGD |
| G |
Smad4 |
SMAD family member 4 |
|
|
ISS |
18 |
70,432,705 |
70,461,541 |
RGD:1599899 |
RGD |
| G |
Smad4 |
SMAD family member 4 |
|
|
ISS |
18 |
70,432,705 |
70,461,541 |
RGD:1599898 |
RGD |
| S |
F344-ApcPircUwm |
|
|
|
IED |
|
|
|
RGD:1601201 |
RGD |
Colorectal Adenomatous Polyposis, Autosomal Recessive
|
| G |
Mutyh |
mutY homolog (E. coli) |
|
|
ISS |
5 |
137,103,958 |
137,115,897 |
RGD:7240710 |
OMIM |
Desmoid disease, hereditary
|
| G |
Apc |
adenomatous polyposis coli |
|
|
ISS |
18 |
26,732,147 |
26,790,383 |
RGD:7240710 |
OMIM |
Polyposis Syndrome, Hereditary Mixed, 2
|
| G |
Bmpr1a |
bone morphogenetic protein receptor, type IA |
|
|
ISS |
16 |
10,061,943 |
10,105,854 |
RGD:7240710 |
OMIM |
Term paths to the root
|